Cargando…
Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study
SUMMARY: Analyses of healthcare data from 30 million individuals in three countries showed that current use of bisphosphonates may be associated with a small increased risk of cardiac valvulopathy (vs. those not exposed within the previous year), although confounding cannot be entirely ruled out. Th...
Autores principales: | Coloma, P. M., de Ridder, M., Bezemer, I., Herings, R. M. C., Gini, R., Pecchioli, S., Scotti, L., Rijnbeek, P., Mosseveld, M., van der Lei, J., Trifirò, G., Sturkenboom, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839043/ https://www.ncbi.nlm.nih.gov/pubmed/26694594 http://dx.doi.org/10.1007/s00198-015-3441-2 |
Ejemplares similares
-
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017) -
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection
por: Pacurariu, Alexandra C., et al.
Publicado: (2015) -
Methylenedioxymethamphetamine-induced toxic valvulopathy
por: Sol, Bastiaan, et al.
Publicado: (2020) -
Can Electronic Health Records Databases Complement Spontaneous Reporting System Databases? A Historical-Reconstruction of the Association of Rofecoxib and Acute Myocardial Infarction
por: Patadia, Vaishali K., et al.
Publicado: (2018) -
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries
por: Coloma, Preciosa M, et al.
Publicado: (2013)